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Abstract: Prenatal exposure to infectious and/or inflammatory insults is increasingly recognized to con-
tribute to the etiology of psychiatric disorders with neurodevelopmental components. Recent research
using animal models suggests that maternal immune activation (MIA) can induce transgenerational ef-
fects on brain and behavior, possibly through epigenetic mechanisms. Using a mouse model of MIA
that is based on gestational treatment with the viral mimeticpoly(I:C) (= <jats:italic>polyriboinosinic-
polyribocytidilic</jats:italic> acid), the present study explored whether the transgenerational effects
of MIA are extendable to dopaminergic dysfunctions. We show that the direct descendants born to
poly(I:C)-treated mothers display signs of hyperdopaminergia, as manifested by a potentiated sensi-
tivity to the locomotor-stimulating effects of amphetamine (Amph) and increased expression of ty-
rosine hydroxylase (<jats:italic>Th</jats:italic>) in the adult ventral midbrain. In stark contrast,
second- and third-generation offspring of MIA-exposed ancestors displayed blunted locomotor responses
to Amph and reduced expression of <jats:italic>Th</jats:italic>. Furthermore, we found increased
DNA methylation at the promoter region of the dopamine-specifying factor, nuclear receptor-related 1
protein (<jats:italic>Nurr1</jats:italic>), in the sperm of first-generation MIA offspring and in the
ventral midbrain of second-generation offspring of MIA-exposed ancestors. The latter effect was further
accompanied by reduced mRNA levels of Nurr1 in this brain region. Together, our results suggest that
MIA has the potential to modify dopaminergic functions across multiple generations with opposite effects
in the direct descendants and their progeny. The presence of altered DNA methylation in the sperm of
MIA-exposed offspring highlights the possibility that epigenetic processes in the male germline play a
role in the transgenerational effects of MIA.
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Transgenerational modification of dopaminergic dysfunctions
induced by maternal immune activation
Ulrike Weber-Stadlbauer 1, Juliet Richetto1,2, Ramona A. J. Zwamborn3,4, Roderick C. Slieker 4,5 and Urs Meyer 1,2
Prenatal exposure to infectious and/or inflammatory insults is increasingly recognized to contribute to the etiology of psychiatric
disorders with neurodevelopmental components. Recent research using animal models suggests that maternal immune activation
(MIA) can induce transgenerational effects on brain and behavior, possibly through epigenetic mechanisms. Using a mouse model
of MIA that is based on gestational treatment with the viral mimeticpoly(I:C) (= polyriboinosinic-polyribocytidilic acid), the present
study explored whether the transgenerational effects of MIA are extendable to dopaminergic dysfunctions. We show that the direct
descendants born to poly(I:C)-treated mothers display signs of hyperdopaminergia, as manifested by a potentiated sensitivity to the
locomotor-stimulating effects of amphetamine (Amph) and increased expression of tyrosine hydroxylase (Th) in the adult ventral
midbrain. In stark contrast, second- and third-generation offspring of MIA-exposed ancestors displayed blunted locomotor
responses to Amph and reduced expression of Th. Furthermore, we found increased DNA methylation at the promoter region of the
dopamine-specifying factor, nuclear receptor-related 1 protein (Nurr1), in the sperm of first-generation MIA offspring and in the
ventral midbrain of second-generation offspring of MIA-exposed ancestors. The latter effect was further accompanied by reduced
mRNA levels of Nurr1 in this brain region. Together, our results suggest that MIA has the potential to modify dopaminergic
functions across multiple generations with opposite effects in the direct descendants and their progeny. The presence of altered
DNA methylation in the sperm of MIA-exposed offspring highlights the possibility that epigenetic processes in the male germline
play a role in the transgenerational effects of MIA.
Neuropsychopharmacology (2021) 46:404–412; https://doi.org/10.1038/s41386-020-00855-w
INTRODUCTION
Infectious or noninfectious maternal immune activation (MIA) is
an environmental risk factor of psychiatric and neurological
disorders with neurodevelopmental etiologies [1]. This epide-
miological association also receives strong support from
experimental work in animal models, which have identified a
broad spectrum of behavioral, physiological, and molecular
alterations in offspring of MIA-exposed mothers [2–4]. In
addition to the neurodevelopmental disturbances emerging in
the direct descendants of exposed mothers, MIA further induces
transgenerational effects on brain and behavior [5, 6]. Thus far,
evidence for the latter effects has been obtained from mouse
models, in which MIA was induced by the viral mimeticpoly(I:C)
[7–9], or the bacterial endotoxin lipopolysaccharide [10]. Using
the poly(I:C)-based mouse model, we previously found transge-
nerational effects of MIA on social and fear-related behaviors,
which were transmitted via the paternal lineage and were stable
until the third generation [9]. These findings are consistent with
the concept of transgenerational nongenetic inheritance of
pathological traits [11] and suggest that epigenetic modifica-
tions in (male) gametes may contribute to, or even mediate, the
transgenerational effects of MIA.
In the present study, we investigated whether the transgenera-
tional effects of MIA are extendable to dysfunctions in the central
dopamine (DA) system. While MIA has the potential to modify
various neurotransmitter systems [1–6], our primary motivation to
focus on the DA system was twofold. First, abnormal functioning
of the DA system is a pathological hallmark of various psychiatric
disorders, including schizophrenia and related psychotic disorders
[12], bipolar disorder [13], and depressive disorders [14]. Second,
functional abnormalities in the DA system have been widely
documented in various rodent models of MIA [15–20], with a
recent extension to a nonhuman primate model of MIA [21]. It
remains unknown, however, whether MIA-induced changes in DA
functions can be transmitted across generations. Exploring the
latter provided the main impetus of the current study.
Based on the existing evidence, there is a genuine possibility for
transgenerational effects on DA functions to occur after MIA.
Indeed, gestational exposure to psychological stressors, which
induce placental inflammation and behavioral anomalies in the
offspring [22], were previously found to induce transgenerational
effects on DA functions in mice, including altered DNA methyla-
tion of dopaminergic genes [23, 24]. Similar transgenerational
effects have also been identified in animal models of maternal
overnutrition [25], which is typically accompanied by obesity-
induced inflammation [26]. Finally, it was recently shown that
infection of male mice with the parasite Toxoplasma gondii (T.
gondii) alters epigenetic profiles of sperm cells and causes
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transgenerational behavioral changes [27]. Even if this recent
study did not specifically explore transgenerational effects of T.
gondii infection on DA functions, it provides support to the
hypothesis that antenatal immune challenges can induce
transgenerational effects via stable epigenetic modifications in
male gametes.
Here, we used the poly(I:C)-based mouse model [4] to study
the transgenerational effects of MIA on DA dysfunctions.
Functional changes in the DA system were assessed by testing
the animals’ locomotor response to the indirect DA receptor
agonist, amphetamine (Amph) [20, 28]. Transcriptional profiling
of tyrosine hydroxylase (Th) and nuclear receptor-related 1
protein (Nurr1; also known as Nr4a2) was conducted to explore
whether MIA induces transgenerational effects on DA-related
gene transcription in the ventral midbrain (vMB), which contains
the majority of post-mitotic DA cells in the mammalian brain
[29]. Whereas Th is the rate-limiting enzyme for DA synthesis
[30], Nurr1 is an obligatory transcription factor for midbrain DA
cell development [31] and exerts a number of molecular
functions in post-mitotic midbrain DA neurons, including the
regulation of Th [32, 33].
In addition to quantifying gene expression of Th and Nurr1,
we assessed the levels of DNA methylation in their promoter
regions. DNA methylation is one of various epigenetic processes,
which together confer short- and long-term changes in gene
expression without altering the DNA code itself [11, 34]. States
of DNA methylation can be maintained during cell division, and
therefore, they may provide a molecular mechanism for the
propagation of heritable changes in gene expression and for
transgenerational non-genetic inheritance of environmentally
acquired traits [11, 34]. Here, we measured DNA methylation of
Th and Nurr1 gene promoters in the vMB to test the hypothesis
that the anticipated dysregulation of Th and Nurr1 transcription
in the vMB of MIA-exposed offspring would be associated with
altered DNA methylation in the corresponding gene promoters
[35]. Furthermore, we assessed DNA methylation of Th and Nurr1
promoter regions in the sperm of MIA-exposed and control
offspring in order to evaluate whether epigenetic modifications
in male gametes may provide a molecular mechanism by which




C57BL6/N mice (Charles River, Sulzfeld, Germany) were used
throughout the study. The animals were kept under a reversed
light–dark cycle (lights off: 7:00 A.M. to 7:00 P.M.) as described
before [9] and in the Supplementary information. All procedures
described in the present study had been previously approved by
the Cantonal Veterinarian’s Office of Zurich, and all efforts were
made to minimize the number of animals used and their suffering.
Timed mating and maternal immune activation in F0 mothers
A reporting guideline checklist for the MIA model [36] is provided
in Supplementary Table S1. To generate the first-generation (F1)
offspring of poly(I:C)-exposed or control mothers, female mice
were subjected to a timed-mating procedure as established
before [9] (for details, see the Supplementary Information).
Pregnant F0 dams on gestation day (GD) 9 were randomly
assigned to receiving either a single injection of poly(I:C)
(potassium salt, P9582, lot number: 086M4045; Sigma–Aldrich,
Switzerland) or vehicle (sterile pyrogen-free 0.9% NaCl) as
described before [9] and in the Supplementary information. For
experimental series involving F0 exposures, a total of 18–24
pregnant dams were used. Maternal behavior was assessed for
every generation (see Supplementary Information and Supple-
mentary Fig. S1).
Allocation of F1 offspring and production of subsequent
generations
All offspring were weaned on postnatal day (PND) 21 and littermates
of the same sex were maintained in groups of 3–5 animals per cage.
Upon reaching adulthood (PND 90 onwards), F1 offspring were
either allocated to behavioral testing (see below), molecular analyses
or breeding, the latter of which served to produce subsequent
generations of immune-challenged or control ancestors. Hence, we
always used behaviorally naïve littermates for molecular analyses
and as breeding pairs to obtain the F2 and F3 generations, thereby
avoiding possible confounds arising from prior behavioral testing.
Timed-mating procedures, as described in the Supplementary
Information, were used to generate F2 and F3 offspring. In one
series of experiments, we dissected the maternal (ML) and paternal
lineages (PL) of F1 poly(I:C) offspring for the subsequent generation
of F2 offspring (Fig. 1a). In another series of experiments, we
generated F3 offspring with poly(I:C)-exposed or control ancestors,
thereby focusing on the PL (Fig. 1b), as fully described in
the Supplementary Information. A summary of animals used in
each experiment is provided in Table 1.
Amphetamine sensitivity test in F1, F2, and F3 offspring
For each generation, behavioral testing started when the offspring
reached PND 90, where we assessed the animals’ sensitivity to
Amph by measuring their locomotor activity in an open field [28, 37]
(for details, see Supplementary Information). To minimize possible
confounds arising from litter effects [38], 1–2 offspring per sex and
litter were randomly selected and tested in the F1 generation,
whereas 1–2 males per litter were selected and tested in the F2 and
F3 generations. Hence, both male and female offspring were used in
the first experimental series (Fig. 2a), whereas behavioral testing in
the F2 and F3 generations were conducted using male offspring
only. Based on our previous studies [9], a sample size of 9–16
offspring per group and sex (Table 1) was selected for the Amph
sensitivity test. The Amph sensitivity test in F1-generation animals
was replicated using an independent cohort of male and female
poly(I:C)-exposed and control offspring (see Supplementary Fig. S2).
Molecular analyses
RNA and DNA was isolated from the vMB and/or sperm of
behaviorally naïve F1, F2, and F3 offspring of MIA-exposed
ancestors and corresponding controls (Fig. 1) as described in
the Supplementary Information. Messenger RNA (mRNA) and DNA
methylation differences were quantified by real-time PCR analysis
and EpiTYPER, respectively, as described in the Supplementary
Information.
Statistical analyses
All data were analyzed by parametric analysis of variance (ANOVA)
followed by Tukey’s post-hoc test for multiple comparisons
whenever appropriate, as described in the Supplementary Infor-
mation. Our primary statistical approach used the individual
offspring as the experimental unit, whereas our secondary
statistical approach considered the treated mothers (i.e., litters)
as experimental unit. The outcomes of the primary statistical
approach are reported in the main manuscript, whereas the
statistical results obtained by the secondary approach are
reported in the Supplementary Information (Supplementary Table
S4–S6). Importantly, the two statistical approaches provided fully
consistent results. Statistical analyses were performed using
StatView (version 5.0) and Prism (version 8.4) and statistical
significance was set at p < 0.05.
RESULTS
Transgenerational modification of amphetamine sensitivity
To identify possible transgenerational effects of poly(I:C)-induced
MIA on dopaminergic functions, we first compared the sensitivity to
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the locomotor-enhancing effects of an acute Amph challenge in F1,
F2, and F3 offspring of control or poly(I:C)-exposed ancestors. The
systemic administration of Amph (2.5mg/kg, i.p.) resulted in a
general increase in locomotor activity, which peaked at around 30
min post-injection. Compared to F1 controls, F1 offspring born to
poly(I:C)-treated mothers displayed a significant increase in Amph-
induced locomotor hyperactivity (Fig. 2a). ANOVA of distance moved
in the open field yielded a significant interaction between prenatal
treatment and drug treatment (F(1,37)= 4.44, p < 0.05); and sub-
sequent post-hoc comparisons confirmed the significant difference
between control and MIA-exposed F1 offspring (p < 0.05) in terms of
the mean distance moved after Amph treatment. The MIA-induced
potentiation of Amph sensitivity in F1 offspring was not significantly
influenced by sex, as there was no significant interaction between
prenatal treatment and sex (F(1,37)= 1.35, p= 0.25), or between
prenatal treatment, drug treatment and sex (F(1,37)= 0.48, p= 0.49).
Furthermore, control and MIA-exposed F1 offspring did not differ in
terms of spontaneous locomotor activity (as measured during the
initial habituation phase of the test) and with regards to the
locomotor response to Sal administration (Fig. 2a).
Contrary to the effects in F1 offspring, second-generation (F2)
offspring of MIA ancestors displayed a significant decrease in
Fig. 1 Breeding scheme used to generate F1, F2, and F3 offspring with control and poly(I:C)-derived ancestors. a Breeding scheme used
to generate F1 and F2 generations with control and immune-challenged ancestors. Pregnant F0 mice were treated with vehicle control (CON)
or poly(I:C) (POL) solution to obtain F1 CON and F1 POL offspring. To obtain F2 POL offspring via the paternal lineage (POL-PL), male F1 POL
offspring were mated with female F1 CON offspring; and to generate F2 POL offspring via the maternal lineage (ML-POL), female F1 POL
offspring were crossed with male F1 CON offspring. F1 CON males and females were crossed to obtain the F2 control lineage (F2 CON).
b Breeding scheme used to obtain the F3 generation with control and immune-challenged ancestors deriving from the paternal lineage (PL).
Pregnant F0 mice were treated with control (CON) or poly(I:C) (POL) solution, and F1 POL males were mated with F1 CON females to generate
F2 POL-PL offspring. F2 POL-PL males were then mated with F2 CON females to obtain F3 POL-PL offspring. CON F3 offspring were generated
by crossing F2 CON males and females.
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Amph-induced locomotor hyperactivity when compared to F2
control offspring. However, this decrease only emerged when F2
offspring of MIA-exposed ancestors were derived from the
paternal lineage (Fig. 2b). F2 offspring of MIA-exposed ancestors
did not display altered locomotor reaction to Amph when they
stemmed from the maternal MIA ancestor lineage (Fig. 2b).
ANOVA of distance traveled in the open field revealed a
significant interaction between ancestor line and drug treat-
ment (F(2, 24)= 4.17, p < 0.05). Subsequent post-hoc comparisons
confirmed the significant difference between F2 offspring of the
paternal MIA ancestor lineage and F2 controls (p < 0.05; Fig. 2b)
in terms of the mean distance moved after Amph treatment.
There were no significant group differences with regards to
spontaneous or Sal-induced locomotor activity in the F2
generation. Together, these findings demonstrate that MIA
modifies Amph sensitivity in the second generation via the
paternal, but not maternal, lineage without altering basal
locomotor activity.
In a next step, we examined whether the transgenerational
modification of Amph sensitivity induced by MIA persists into the
third (F3) generation. For this purpose, we generated F3 control
offspring and F3 offspring of MIA-exposed ancestors deriving from
the paternal lineage as illustrated in Fig. 1b. Consistent with the
effects in the second generation, F3 offspring of the paternal MIA
ancestor lineage displayed a decrease in Amph-induced locomotor
hyperactivity when compared to F3 controls (Fig. 2c). ANOVA of
distance moved in the open field revealed a significant interaction
between ancestor line and drug treatment (F(1, 28)= 5.43, p < 0.05);
and subsequent post-hoc comparisons confirmed the significant
difference between F3 offspring of the paternal MIA ancestor
lineage and F3 controls (p < 0.01) in terms of the mean distance
moved after Amph treatment (Fig. 2c). There were no significant
group differences with regards to spontaneous or Sal-induced
locomotor activity in the F3 generation. Together, these findings
demonstrate that transgenerational modification of Amph sensitivity
induced by MIA persists into the third generation of offspring.
Transgenerational modification of dopaminergic gene expression
in the midbrain
To identify possible molecular correlates of the transgenerationally
modified sensitivity to Amph, we assessed the mRNA levels of key
genes for DA functioning, namely Th and Nurr1, in the adult vMB
of F1, F2, and F3 offspring of MIA-exposed ancestors and
corresponding controls. For F2 and F3 offspring, we included
generations that were derived from the paternal lineage of MIA-
exposed ancestors (as illustrated in Fig. 1). We focused on
transcriptional changes in the vMB as it contains the majority of
dopaminergic cell bodies in the mammalian brain [29].
As depicted in Fig. 3a, ThmRNA levels were significantly increased
in F1 offspring born to poly(I:C)-treated mothers relative to F1
controls (t(12)= 3.04, p < 0.01), whilst there were no significant group
differences in terms of Nurr1 mRNA levels in F1 offspring. On the
other hand, F2 (Fig. 3b) and F3 (Fig. 3c) offspring of the paternal MIA
ancestor lineage displayed significantly reduced mRNA levels of Th
(F2: t(14)= 2.23, p < 0.05; F3: t(12)= 2.42, p < 0.05) and Nurr1 (F2: t(14)
= 2.98, p < 0.01; F3: t(12)= 2.21, p < 0.05) compared with correspond-
ing control offspring. These findings thus demonstrate that MIA
modifies the expression levels of DA-related genes across multiple
generations, with opposing effects in the direct descants (F1
generation) and their progeny (F2 and F3 generation).
Transgenerational effects on DNA methylation at Th and Nurr1
promoter regions
We further explored whether the transgenerational modification of
Th and Nurr1 expression induced by MIA (Fig. 3) would be
accompanied by altered DNA methylation in brain and sperm
tissue. To this end, we measured DNA methylation levels of
individual CpGs within the promoter region of Th and Nurr1 in the
vMB of MIA-exposed F1 and F2 offspring and corresponding
controls, and in the sperm of F1 offspring of MIA-exposed mothers
and F1 controls.
DNA at the promoter region of Th was generally hypomethylated
in the vMB of F1 offspring born to MIA-exposed mothers relative to
F1 controls (main effect of prenatal treatment: F(1,16)= 4.64, p < 0.05).
This effect was mainly driven by reductions in DNA methylation at
CpG position 2 and, to a lesser extent, CpG position 9 in the selected
amplicon (Fig. 4a), as reflected by the significant interaction of
prenatal treatment and CpG position (F(8,128)= 3.35, p < 0.01).
Subsequent post-hoc comparisons confirmed the significant
decrease in Th DNA methylation at CpG position 2 (p < 0.05) in
MIA-exposed F1 compared to F1 controls and revealed a statistical
trend level (p= 0.059) for Th DNA methylation at CpG position 9
(Fig. 4a). DNA methylation levels at the promoter region of Nurr1
were not affected by MIA in the vMB of F1 offspring (Fig. 4a).
By contrast, MIA significantly affected DNA methylation of
Nurr1, but not Th, in the sperm of F1 offspring (Fig. 4b). For the
former gene, ANOVA revealed a significant main effect of
prenatal treatment (F(1,19)= 5.13, p < 0.05), while for the latter
gene, there were no significant main effects or interactions
involving the between-subjects factor of prenatal treatment.
The effects of MIA on sperm DNA methylation of Nurr1, as
observed in F1 offspring of MIA-exposed mothers, were mirrored in
Table 1. The table specifies the number of offspring used in each experimental procedure.
Experiment Number of offspring per litter, group (CON or POL) and generation (F1–F3)
F1 F2 F3
Amph sensitivity (Fig. 2) Amph N (CON)= 12 (7m, 5f ) [10]
N (POL)= 11 (6m, 5f ) [11]
N (CON)= 5m [5]
N (POL-PL)= 5m [5]
N (POL–ML)= 5m [5]
N (CON)= 9m [8]
N (POL-PL)= 9m [9]
Sal N (CON)= 11 (6m, 5f ) [10]
N (POL)= 11 (6m, 5f ) [11]
N (CON)= 5m [5]
N (POL-PL)= 5m [5]
N (POL-ML)= 5m [5]
N (CON)= 7m [7]
N (POL-PL)= 7m [7]
Gene expression (Fig. 3) N (CON)= 7m [7]
N (POL)= 7m [7]
N (CON)= 9m [7]
N (POL-PL)= 7m [7]
N(CON)= 7m [6]
N (POL-PL)= 7m [6]
DNA methylation (Fig. 4) Brain N (CON)= 9m [9]
N (POL)= 9m [9]
N (CON)= 8m [7]
N (POL-PL)= 8m [7]
n/a
Sperm N (CON)= 10m [10]
N (POL)= 11m [10]
n/a n/a
The number in square brackets denotes the number of litters, from which the animals were obtained. f, females; m, males.
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the vMB of F2 offspring of the paternal MIA ancestor lineage
(Fig. 4c). Compared to F2 controls, F2 offspring of the paternal MIA
ancestor lineage displayed a small but significant (main effect of
ancestor line: F(1,14)= 4.88, p < 0.05) increase in DNA methylation at
the Nurr1 promoter region in the vMB. Consistent with the effects
observed in F1 sperm, there were no significant group effects or
interactions involving the between-subjects factor of ancestor line in
the analysis of DNA methylation of Th in the F2 vMB (Fig. 4c).
DISCUSSION
The present study provides the first experimental evidence for
transgenerational effects of MIA on the central DA system. Using
the poly(I:C)-based MIA model in mice, our data demonstrate that
behavioral and transcriptional indices of DA functions are not only
altered in MIA-exposed F1 offspring, but also in their progeny.
Most intriguingly, however, the direction of changes was
diametrically opposite in the direct descendants of poly(I:C)-
Fig. 2 Effects of maternal immune activation on the locomotor reaction to acute systemic amphetamine challenge in F1, F2, and F3
offspring. All animals were first placed into the open field and allowed to habituate for 30min, after which they were injected with
amphetamine (Amph; 2.5 mg/kg) or saline (Sal) solution. The line plots show the distance moved as a function of 5-min-bins during the initial
habituation and subsequent drug phase; the bar plots depict the mean distance moved during the drug phase. a Locomotor activity levels in
F1 offspring of control (CON) and poly(I:C)-treated (POL) mothers. The data represent male and female offspring together, as there were no
sex-specific effects of MIA on Amph sensitivity in F1 offspring. b Locomotor activity levels in male F2 CON offspring and male F2 POL offspring
generated via the maternal (POL-ML) or paternal (POL-PL) lineages. c Locomotor activity levels in male F3 CON offspring and male F3 POL
offspring generated via the paternal lineage (POL-PL). *p < 0.05, **p < 0.01, and ***p < 0.001, based on post-hoc comparisons. All values are
means+ SEM. The numbers of animals in each group are provided in Table 1.
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treated mothers and in subsequent generations. Compared to F1
control offspring, MIA-exposed F1 offspring displayed a poten-
tiated sensitivity to the locomotor-stimulating effects of Amph
and increased Th expression in the vMB. These changes are
consistent with numerous previous findings in rodent [15–20] and
non-human primate [21] models of MIA and are reminiscent of a
hyperdopaminergic state, which in turn is a pathological hallmark
of (acute) psychosis in patients with schizophrenia and related
disorders [12, 39]. In stark contrast, F2 and F3 offspring of
immune-challenged ancestors displayed signs of hypodopami-
nergia, as indicated by the presence of blunted locomotor
responses to Amph and reduced expression of Th and Nurr1 in
the vMB. Together, these findings identify a novel role of MIA in
modifying DA functions across multiple generations.
The transgenerational transmission of MIA-induced changes in
Amph sensitivity occurred via the paternal lineage and was
paralleled by epigenetic modifications in sperm DNA methylation.
The paternal mode of the transgenerational modification of DA
functions is consistent with our previous study [9], which identified a
critical role of the paternal lineage in mediating non-genetic
inheritance of social and fear-related abnormalities after MIA. The
paternal mode of transmission is also consistent with other models
of early-life adversities, such as prenatal or neonatal stress [40].
Hence, there is increasing evidence to suggest that stable epigenetic
modifications in sperm cells may represent a mechanism by which
exposure to environmental adversities, including immune chal-
lenges [40], can induce pathological effects across generations. In
addition to our findings presented here, experimental support for
the latter was also found in a recent study showing that pathogenic
infection with T. gondii alters small-RNA profiles in sperm and
induces transgenerational effects on behavior [27].
Our previous transgenerational study in the poly(I:C)-based MIA
model further demonstrated that the precise nature of behavioral
anomalies can differ from one generation to the next [9]. For
example, we found sociability and fear-related behaviors to be
affected similarly in MIA-exposed F1 offspring and their F2 and F3
progeny, whereas behavioral despair, as assessed using the
Porsolt forced swim test, was found to emerge only in the F2
and F3 offspring of immune-challenged ancestors, but not in the
direct descendants (F1) born to poly(I:C)-treated mothers [9].
Based on experimental work in rodent models of chronic stress
exposure [11], it has been suggested that “silent molecular
carriers” may cause patterns of non-genetic transgenerational
inheritance that are characterized by the emergence of novel
phenotypes across generations. According to this hypothesis, the
exposure itself does not cause overt effects on phenotype-
relevant somatic tissues in F1 offspring, but is still able to
reprogram primordial germ cells of the F1 generation. The latter
effect may then affect developmental processes following
fertilization of the oocyte and precipitate the appearance of a
certain phenotype in subsequent generations, even if it was not
present in the F1 generation [11].
Notably, the data presented here suggest that some of the
transgenerational effects of MIA can be modified to take opposite
directions of abnormalities (e.g., from hyper- to hypodopaminer-
gia). Besides potentiated Amph sensitivity, the spectrum of
behavioral and neurochemical phenotypes emerging in F1
offspring of poly(I:C)-treated mothers involves other psychosis-
related dysfunctions, including disruption of sensorimotor gating
[9, 16], deficits in selective attention [15, 16] and elevations in
central DA levels [41]. On the other hand, the behavioral
phenotypes emerging in F2- and F3-generation offspring of
MIA-exposed ancestors, as identified here and before [9], rather
recapitulate disorders that are characterized by downregulated DA
activity, such as major depressive disorders [14]. Currently, a causal
explanation for this dichotomy is lacking. On speculative grounds,
however, the contrarian directionality of effects in F1-generation
versus F2- and F3-generation offspring may be related to
differential and generation-dependent epigenetic effects of MIA
in somatic tissue (e.g., brain) and germ cells (e.g., sperm) [11].
Here, we found that MIA increased DNA methylation of the Nurr1
promoter in the sperm of F1 offspring, demonstrating that this
early life adversity has the capacity of inducing epigenetic
modifications in germ lines. A similar pattern of Nurr1 hyper-
methylation was observed in the F2 generation of MIA-exposed
ancestors, whereas DNA of the Nurr1 promoter was not
differentially methylated by MIA in the F1 generation. Moreover,
Nurr1 hypermethylation in the vMB of F2 MIA offspring was
accompanied by reduced Nurr1 mRNA levels in this brain region.
Together, these generation-dependent effects are consistent with
the notion that a certain environmental exposure such as MIA is
still able to reprogram primordial germ cells of the F1 generation
(and cause corresponding transcriptional changes in subsequent
generations) even if it did not lead to the same changes in somatic
cells of F1 offspring [11].
In keeping with the critical importance of Nurr1 in DA cell
development and functions [31–33], we also deem impaired Nurr1
transcription to be a contributing factor for precipitation of
hypodopaminergia in the F2 generation of MIA-exposed ances-
tors. Indeed, Nurr1 is an obligatory transcription factor for
Fig. 3 Effects of maternal immune activation on the expression of tyrosine hydroxylase (Th) and nuclear receptor-related 1 protein
(Nurr1) in the ventral midbrain of male F1, F2 and F3 offspring. The graphs depict the normalized levels of Th and Nurr1 mRNA levels (fold
changes) of individual animals measured by quantitative RT-PCR. a Th and Nurr1 mRNA levels in F1 offspring of control (CON) and poly(I:C)-
treated (POL) mothers. b Th and Nurr1mRNA levels in F2 CON offspring and F2 POL offspring generated via the paternal lineage (POL/PL). c Th
and Nurr1 mRNA levels in F3 CON offspring and F3 POL offspring generated via the paternal lineage (POL/PL). *p < 0.05 and **p < 0.01, based
on independent Student’s t tests (two-tailed).
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midbrain DA cell development [31] and exerts a number of
molecular functions in post-mitotic midbrain DA neurons, includ-
ing the regulation of Th expression [32, 33]. Accordingly, reduced
expression of Nurr1 in post-mitotic DA neurons, be it induced by
genetic [32, 33, 42] or environmental [43–45] manipulations, is
typically associated with blunted Th expression. Our study is
consistent with these findings and revealed a similar association
between reduced Nurr1 and Th expression.
We further found that MIA can alter DNA methylation of the Th
promoter, albeit this effect was restricted to the vMB of MIA-
exposed F1 offspring. The effect of MIA on Th DNAmethylation in F1
MIA offspring extends previous investigations in poly(I:C)-based
rodent models of MIA, which have identified altered DNA
methylation patterns in other brain regions, including prefrontal
cortex [46, 47], hypothalamus [48] and striatum [49]. Interestingly,
genome-wide profiling of DNA methylation in F1 offspring born to
Fig. 4 Effects of maternal immune activation on DNA methylation at promoter regions of tyrosine hydroxylase (Th) and nuclear receptor-
related 1 protein (Nurr1) in the ventral midbrain (vMB) and sperm cells of male offspring. The line plots depict percent DNA methylation of
specific CpGs in selected amplicons, and the scatter plots show the mean percent DNA methylation across all individual CpGs included in the
corresponding amplicon. Amplicon and primer sequences and position of CpGs in each amplicon are provided in Supplementary Table S2
and S3. a DNA methylation levels of Th and Nurr1 in the vMB of F1 offspring of control (CON) and poly(I:C)-treated (POL) mothers. *p < 0.05 and
#p= 0.059, based on ANOVA and post-hoc tests. b DNA methylation levels of Th and Nurr1 in the sperm of F1 CON and POL offspring. *p <
0.05, based on ANOVA. c DNA methylation levels of Th and Nurr1 in the vMB of F2 CON offspring and F2 POL offspring generated via the
paternal lineage (POL/PL). *p < 0.05, based on ANOVA.
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poly(I:C)-treated mice suggests that exposure to this environmental
factor leads to a global overrepresentation of DNA hypomethylation
in somatic tissue such as the prefrontal cortex [47] and hypotha-
lamus [48]. The present data showing reduced Th DNA methylation
in the vMB of MIA-exposed F1 offspring is consistent with these
previous reports and suggest that MIA has the capacity to reduce
DNA methylation in somatic cells of the midbrain regions as well.
Reduced Th promoter DNA methylation was further associated with
increased Th expression in the vMB, which in turn is in line with the
permissive transcriptional effects of DNA hypomethylation in gene
promoter regions [50, 51]. Additional investigations will be required,
however, to test whether hypomethylation of the Th promoter is
causally linked with increased Th expression in the vMB of F1
offspring born to MIA-exposed mothers.
We acknowledge a number of other limitations in our study. First,
our molecular analyses only included two specific genes relevant
for DA development and functions, namely Th and Nurr1. Arguably,
the molecular machinery pertaining to DA signaling involves an
intricate network of genes [52, 53], and therefore, an extension to
other gene sets would be desirable to further examine the
specificity of our findings. A second limitation of our study is that
we did not include female mice in the behavioral studies of F2- and
F3-generation offspring, whereas both sexes were included in the
F1 generation. Hence, it remains to be explored whether MIA
induces similar transgenerational effects on Amph sensitivity and
DA-related molecular profiles in males and females. An extension of
our investigations to the female sex also appears crucial in view of
the fact that distinct molecular mechanisms may drive the
emergence of similar phenotypes in males and females [54]. Third,
the postulated involvement of epigenetic modifications in sperm
DNA, which may contribute to the modification of DA functions in
the F2 generation of immune-challenged ancestors, still awaits
verification through additional analyses. While our study focused on
DNA methylation in promoter regions, there are numerous other
epigenetic processes that may contribute to the transgenerational
effects of MIA [5, 6], including altered expression of non-coding
RNAs such microRNAs [55, 56]. Likewise, the germline dependence
of the MIA-induced transgenerational effects on DA functions
should be explored further. While paternal experience can influence
offspring development via germline inheritance, mothers can also
serve as a modulating factor in determining the impact of paternal
influences on offspring development [40]. The lack of overt changes
in maternal behavior (Supplementary Fig. S1), however, under-
scores the importance of male gametes underlying the transge-
nerational effects of MIA in our study. The germ-line dependence of
MIA-induced changes should be further ascertained using experi-
mental methods that can establish mechanistic causality. Artificial
insemination [57, 58], for example, may be used to test the
hypothesis that the modification of DA functions in the F2
generation of immune-challenged ancestors involves epigenetic
modifications of sperm cells.
Despite these limitations, we conclude that MIA has the potential
to modify DA functions across generations, at least within well-
defined experimental settings. The broader relevance of these data
is that they show that the transgenerational modification of a DA-
related functional readout after MIA is mirrored by a transgenera-
tional modification of molecular components of the central DA
system, highlighting a remarkable correspondence of the two
domains. To the best of our knowledge, our study is the first
demonstration of altered sperm DNA methylation after MIA. Our
findings thus suggest that MIA can induce epigenetic modifications
in both somatic and (male) germ cells, which in turn may point to a
potential mechanism by which MIA can induce pathologies in
multiple generations even in the absence of additional immune
exposures. Further studies on the identification of epigenetic and
transgenerational effects in MIA-induced neurodevelopmental dis-
orders may help to identify complex patterns of transgenerational
disease transmission beyond genetic inheritance.
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